Chapter 6: Meeting industry requirements

Download chapter (PDF 452kb)

Chapter at a glance

  • We have sought to design a mechanism to which industry will respond by increasing R&D on vaccines for diseases occurring mainly in developing countries.
  • Industry is attracted to the concept of payment for results; the market mechanism fits their business model well and preserves the role of intellectual property rights and market sales financing commercial investment in pharmaceutical R&D.
  • Our consultations revealed a range of priorities for the commitment from different parts of industry.
  • An advance market commitment would be of value to developingcountry suppliers, which often do not benefit from other incentive arrangements.
  • Complementary measures are needed to improve the procurement of existing vaccines, improve demand forecasts and increase funding for existing drugs and vaccines.

Read full chapter (PDF 452kb)

Get Updates

Twitter   Facebook   YouTube   RSS   Podcasts